Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator’s choice of chemotherapy in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL) von Phillips, Adrienne Alise, Fields, Paul, Hermine, Olivier, Taylor, Graham, Delioukina, Maria L., Horwitz, Steven M., Ramos, Juan Carlos, Meniane, Jean Côme, Barta, Stefan K., Dwyer, Karen M., Kurman, Michael R., Saunders, Andrew, Grebennik, Dmitri O., Conlon, Kevin

Volltext